𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon therapy for hepatitis

✍ Scribed by Zuckerman, Arie J.

Book ID
109702697
Publisher
Nature Publishing Group
Year
1976
Tongue
English
Weight
138 KB
Volume
263
Category
Article
ISSN
0028-0836

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Benefits and risks of interferon therapy
Benefits and risks of interferon therapy for hepatitis B
✍ Robert Perrillo πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 120 KB

Alpha interferon is the only licensed drug for hepatitis B with immunomodulatory as well as viral inhibitory properties. Potential advantages of interferon compared to nucleoside analogs include a lack of drug resistance, a finite and defined treatment course, and a higher likelihood for hepatitis B

Autoantibodies during Ξ±-interferon thera
Autoantibodies during Ξ±-interferon therapy for chronic hepatitis B
✍ G. Fattovich; C. Betterle; L. Brollo; B. Pedini; G. Giustina; G. Realdi; A. Albe πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 424 KB

The development of autoantibodies and autoimmune reactions has been reported during and after interferon (IFN) therapy. Thirteen different antibodies from the sera of 32 patients with chronic hepatitis B treated with alpha-interferon (alpha-IFN) were tested. Seventeen HBeAg-positive patients receive